参考文献/References:
[1].Joseph P,Leong D,Mckee M,et al.Reducing the global burden of cardiovascular disease,part 1[J].Circ Res,2017,121(6):677-694.
[2].Pe?a B,Laughter M,Jett S,et al.Injectable hydrogels for cardiac tissue engineering[J].Macromol Biosci,2018,18(6):e1800079.
[3].Waters R,Alam P,Pacelli S,et al.Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue[J].Acta Biomaterialia,2017,69:95-106.
[4].Chen FM,Liu X.Advancing biomaterials of human origin for tissue engineering[J].Prog Polym Sci,2016,53:83-168.
[5].Brisa Pe?a,Susan Jett,Teisha JR,et al.Injectable hydrogels for cardiac tissue engineering[J].Macromol Biosci,2018,18(6):e1800079.
[6].Radhika N,Vladimir P.Torchilin hydrogels and their applications in targeted drug delivery[J] .Molecules,2019,24(3):603.
[7].Badimon L,Borrell M.Microvasculature recovery by angiogenesis after myocardial infarction[J].Curr Pharm Des,2018,24(25):2967-2973.
[8].Rebou?as JS,Santos-Magalh?es NS,Formiga FR.Cardiac regeneration using growth factors: advances and challenges[J].Arq Bras Cardiol,2016,107(3):271-275.
[9].Riederer MS,Requist BD,Payne KA,et al.Injectable and microporous scaffold of densely-packed,growth factor-encapsulating chitosan microgels[J].Carbohydr Polym,2016,152:792-801.
[10].O’Dwyer J,Murphy R,Dolan EB,et al.Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium[J].Drug Deliv Transl Res,2020,10(2):440-454.
[11].Zipeng L,Hidetoshi M,Jun-Ichiro J,et al.Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model[J].Gen Thorac Cardiovasc Surg,2018,66(11):641-647.
[12].Fan Z, Xu Z, Niu H,et al.Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote[J].J Control Release,2019,311-312:233-244
[13].Hopfner U,Maan ZN,Hu MS,et al.Deferoxamine enhances the regenerative potential of diabetic Adipose Derived Stem Cells[J].J Plast Reconstr Aesthet Surg,2020,73(9):1738-1746.
[14].Vignesh S,Sivashanmugam A,Annapoorna M,et al.Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis[J].Colloids Surf B Biointerfaces,2017,161:129-138.
[15].Ding Z, Zhou M, Zhou Z,et al.Injectable silk nanofiber hydrogels for sustained release of small-molecule drugs and vascularization[J].ACS Biomater Sci Eng,2019,5(8):4077-4088.
[16].Paige H,Lakshmi SN.Deferoxamine:an angiogenic and antioxidant molecule for tissue regeneration[J].Tissue Eng Part B Rev,2019,25(6):461-470.
[17].Lloyd-Jones DM,Huffman MD,Karmali KN,et al.Estimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients: the million hearts longitudinal ASCVD risk assessment tool[J].J Am Coll Cardiol,2017,69(12):1617-1636.
[18].Inoue T,Inoguchi T,Sonoda N,et al.GLP-1 analog liraglutide protects against cardiac steatosis,oxidative stress and apoptosis in streptozotocin-induced diabetic rats[J].?Atherosclerosis,2015,240(1):250-259.
[19].Quan Q,Lei L,Haiqing L,et al.Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction[J].Int J Nanomedicine,2017,12:4835-4848.
[20].Rahnavard M,Hassanpour M,Ahmadi M,et al.Curcumin ameliorated myocardial infarction by inhibition of cardiotoxicity in the rat model[J].Cell Biochem,2019,120:11965-11972.
[21].Silva RA,Souza MF,Oliveira DA,et al.Preparation of curcumin-loaded nanoparticles and determination of the antioxidant potential of curcumin after encapsulation[J].?Polímeros,2016,26:207-214.
[22].Umerska A,Gaucher C,Oyarzun AF,et al.Polymeric nanoparticles for increasing oral bioavailability of curcumin[J].?Antioxidants,2018,7(4):46.
[23].Sakineh O,Mozhgan P,Ali K.Co-delivery of doxorubicin and curcumin by a pH-sensitive,injectable,and in situ hydrogel composed of chitosan,graphene,and cellulose nanowhisker[J].Carbohydrate Polymers,2020,231:1-8.
[24].Chen G,Li J,Song M,et al.A mixed component supramolecular hydrogel to improve mice cardiac function and alleviate ventricular remodeling after acute myocardial infarction[J].Adv Funct Mater,2017,27(34):1-8.
[25].Zhang X, Wang Q, Wang X,et al.Tanshinone ⅡA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway[J].Biomed Pharmacother,2019,112:108599.
[26].Wang W,Chen J,Li M,et al.Rebuilding postinfarcted cardiac functions by injecting TⅡA@PDA nanoparticle-cross-linked ROS-sensitive hydrogels[J].ACS Appl Mater Interfaces,2019,11(3):2880-2890.
[27].Tardif JC,Kouz S,Waters DD,et al.Efficacy ?and? Safety? of? Low-Dose? Colchicine? after? Myocardial? Infarction[J].N Engl J Med,2019,381(26):2497-2505.
[28].Chen Y,Shi J,Zhang Y,et al.An injectable thermosensitive?hydrogel?loaded with an ancient natural?drug?colchicine for myocardial repair after infarction[J].J Mater Chem B,2020,8(5):980-992.
相似文献/References:
[1]王铁华,郑景辉,莫云秋.蛋白质组学在心肌梗死中的研究进展[J].心血管病学进展,2015,(5):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
WANG Tiehua,ZHENG Jinghui,MO Yunqiu.Research Progress of Proteomics in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2015,(6):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
[2]孙洋.基质金属蛋白酶与心肌梗死后心脏重构[J].心血管病学进展,2019,(8):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
SUN Yang.Matrix Metalloproteinases in Cardiac Remodeling after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
[3]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(6):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[4]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(6):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
[5]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(6):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[6]邹先明 赵然尊.长链非编码RNA ANRIL与心血管疾病的研究进展[J].心血管病学进展,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
ZOU Xianming,ZHAO Ranzun.Long Non-Coding RNA ANRIL and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(6):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[7]王茜 李晶洁.细胞学机制在调控心肌梗死后炎症反应中的研究进展[J].心血管病学进展,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
WANG QianLI Jingjie.Cytological Mechanisms in Regulation of The Post-infarction Inflammatory Response[J].Advances in Cardiovascular Diseases,2020,(6):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
[8]黄柳,张瑞宁,田小超,等.内皮祖细胞与冠心病患者CD14CD16+单核细胞共培养后移植心肌梗死大鼠对血管密度及心肌梗死面积的影响[J].心血管病学进展,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
HUANG Liu,ZHANG Ruining,TIAN Xiaochao,et al.Effects of Co-cultured Endothelial Progenitor Cells and CD14++CD16+ Monocytes from Coronary Heart Disease Patients on Vascular Density and Myocardial Infarction Size in Transplanting Myocardial Infarction Rats[J].Advances in Cardiovascular Diseases,2020,(6):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
[9]刘玉婷,贾锋鹏.骨膜蛋白与心血管疾病的研究进展[J].心血管病学进展,2020,(3):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
LIU Yuting,JIA Fengpeng.Roles of Periostin in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(6):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
[10]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(6):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
[11]李彬 蒋学俊.水凝胶改善心肌梗死后心脏生物力学重构的研究进展[J].心血管病学进展,2022,(8):691.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.006]
LI Bin,JIANG Xuejun.Biomechanics of Hydrogel After Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(6):691.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.006]